Mononuclear Cytotoxicity and Proliferation Towards Glucose Stimulated Rodent Pancreatic Islet Cells

References

• Buschard K. The functional state of the beta cells in the pathogenesis of insulin dependent diabetes mellitus. Autoimmunity 1991; 10: 65–70
   PubMed Web of Science ®Google Scholar
• Kolb H., Ben-Nun A., Cohen I. R., Barberena I., Kiesel U. Autoimmune T-lymphocytes with specificity for pancreatic islet antigens. Immunology Letters 1985; 9: 29–32
   Google Scholar
• Roep B. O., Arden S., de Vries R. R. P., Hutton J. C. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345: 632–634
   PubMed Web of Science ®Google Scholar
• Botazzo G. F. Death of beta cell: Homicide or suicide?. Diab. Med. 1986; 3: 119–30
   Google Scholar
• Di Mario U., Dotta F. Modulation of Antigen Expression in Relation to Intervention Strategies in Type 1 Diabetes. Diab. Metab. Rev. 1993; 9: 245–249
   Google Scholar
• Pipeleers D., Kiekens R., Ling Z., Wilikens A., Schuit F. Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 1994; 37((supplement 2))S57–S64
   Google Scholar
• Gotfredsen C. F., Buschard K., Frandsen E. K. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28: 933–935
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Maclaren N. K., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39: 933–937
   PubMed Web of Science ®Google Scholar
• Gottlieb P. A., Handler E. S., Appel M. C., Greiner D. L., Mordes J. P., Rossini A. A. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats. Diabetologia 1991; 34: 296–300
   PubMedGoogle Scholar
• Bertrand S., De Paepe M., Vigeant C., Yale J.-F. Prevention of adoptive transfer in BB rats by prophylactic insulin treatment. Diabetes 1992; 41: 1273–1277
   PubMedGoogle Scholar
• Like A. A. Insulin injections prevent diabetes in Bio Breeding/Worcester (BB/Wor) rats. Diabetes 1986; 35(supplement 1)74A
   Google Scholar
• Portha B., Picon L. Insulin treatment improves the spontanous remission of neonatal streptozotocin diabetes in the rat. Diabetes 1982; 31: 165–169
   Google Scholar
• Thivolet C. H., Goillot E., Bedossa P., Durand A., Bonnard M., Orgiazzi J. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 1991; 34: 314–319
   PubMed Web of Science ®Google Scholar
• Shah S. C., Malaone J. I., Simpson N. E. A randomised trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. New Eng. J. Med. 1989; 320(1)550–554
   Google Scholar
• Colman P. G., Nayak R. C., Campbell I. L., Eisenbarth G. S. Binding of cytoplasmatic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 1988; 37: 645–652
   PubMed Web of Science ®Google Scholar
• West D. B., Seino Y., Woods S. C., Porte D. Ventro-medial hypothalamic lesions increase pancreatic sensitivity to streptozotocin in rats. Diabetes 1980; 29: 948–951
   Google Scholar
• Buschard K., Buch I., Molsted-Pedersen L., Hougaard P., Kuhl C. Increased incidence of true type I diabetes during pregnancy. Brit. Med. J. 1987; 294: 275–279
   PubMed Web of Science ®Google Scholar
• Buschard K., Brogren C. H., Rørpke C., Rygaard J. Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2. APMIS 1988; 96: 342–346
   PubMed Web of Science ®Google Scholar
• Aaen K., Rygaard J., Josefsen K., et al. Dependence of antigen expression on functional state of beta-cells. Diabetes 1990; 39: 697–701
   PubMed Web of Science ®Google Scholar
• Appel M. C., Dotta F., O'Neil J. J., Eisenbarth G. S. B-cell activity regulates the expression of islet antigenetic determinants. Diabetologia 1989; 32: 461 A
   Google Scholar
• Mordes J. P., Desemone J., Rossini A. A. The BB rat. Diab. Metab. Rev. 1987; 3: 725–750
   PubMed Web of Science ®Google Scholar
• Nerup J., Andersen O. O., 8endixen G., Egeberg J., Poulsen J. E. Antipancreaticcellular hypersensitivity in diabetes mellitus. Diabetes 1971; 20: 424–427
   PubMed Web of Science ®Google Scholar
• Diaz J.-L., Ways J., Hammonds P. T-lymphocyte lines specific for Glutamic Acid Decarboxylase (GAO) the 64K beta-cell antigen of IDDM. Diabetes 1992; 41: 118–121
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Aanstoot H. J., Christgau S., et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-sythesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Michelsen B. K., Petersen J. S., Boel E., Mødrup A., Dyrberg T., Madsen O. D. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 1991; 88: 8754–8758
   PubMedGoogle Scholar
• Kaufman D. L., Erlander M. G., Clare-Salzier M., Atkinson M. A., Maclaren N. K., Tobin A. J. Autoimmunity to two forms of Glutamat Decarboxylase in insulin-dependent Diabetes Mellitus. J. Clin. Inv. 1992; 89: 283–292
   PubMed Web of Science ®Google Scholar
• Bjoerk E., Kaempe O., Andersson A., Karlsson F. A. Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia 1992; 32: 490–493
   Google Scholar
• Nakamura N., Woda B. A., Tafuri A., et al. Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro. Diabetes 1990; 39: 836–843
   PubMed Web of Science ®Google Scholar
• Ashcroft S. J. H., Hammonds P., Harrison D. E. Insulin secretory responses of a clonal cell line of simian virus 40 transformed B cells. Diabetologia 1986; 29: 727–733
   Google Scholar
• Roep B. O., Kallan A. A., Hazenbos W. L., et al. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type I diabetes. Lancet 1991; 337: 1439–1441
   PubMed Web of Science ®Google Scholar
• Feige U., Cohen I. R. The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice. Springer Semin. Immunopathol. 1991; 13: 99–113
   PubMedGoogle Scholar
• Nomoto K., Yoshikai Y. Heat-shock proteins and immunopathology: regulatory role of heat-shock protein-specific T cells. Springer Semin. Immunopathol. 1991; 13: 63–80
   Google Scholar
• Elias D., Reshef T., Birk O. S., Van der Zee R., Walker M. D., Cohen I. R. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA. 1991; 88: 3088–3091
   PubMed Web of Science ®Google Scholar
• Pedersen C. R., Josefsen K., Bock T., Hansen S. V., Buschard K. Beta-cell expression of 65-kDa heat-shock protein mRNA is function- and age-dependent. APMIS 1992; 100: 765–771
   Google Scholar
• Sandler S., Bendtzen K., Eizirik D. L., Strandell E., Welsh M., Welsh N. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration. Immunology Letters 1990; 26: 245–252
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Strandell E., Sandler S. Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia 1988; 31: 168–174
   PubMed Web of Science ®Google Scholar
• Palmer J. P., Helqvist S., Spinas G. A., et al. Interaction of Beta-Cell Activity and IL-1 Concentration and exposure Time in Isolated Rat Islets of Langerhans. Diabetes 1989; 38: 1211–1216
   PubMed Web of Science ®Google Scholar
• Burkart V., Brenner H.-H., Hartmann B, Kolb H. Metabolic activation improves the resistance of islet cells to toxic attack. European Association for the Study of Diabetes 30th annual meeting, Dusseldorf, 1994; A97: 377, [Abstract]
   Google Scholar
• Koevary B. S., Williams D. E., Williams R. M., Chick W. L. Passive transfer of diabetes from BB/W to Wistar-Furth rats. J. Clin. Invest. 1985; 75: 1904–1907
   PubMedGoogle Scholar
• Buschard K. The thymus-dependent immune system in the pathogenesis of type I (insulin-dependent) diabetes mellitus. Danish Med. Bul. 1985; 32: 139–151
   PubMedGoogle Scholar
• Weringer E. J., Like A. A. Diabetes mellitus in the BB/W rat. Insulitis in pancreatic islet grafts after transplantation in diabetic recipients. AJP 1986; 125: 107–112
   Google Scholar
• Debray-Sachs M., Boitard C., Timsit J., Bach J. F. Specific anti-islet immuniy in NOD mice: In vitro studies. The immunology of diabetes mellitus, M. A. Jaworski, G. O. Molnar, R. V. Rajotte, B. Singh. Int. congress series 717., 1986; 147, Excepta Medica 1986.
   Google Scholar
• Pipeleers D., Ling Z. Pancreatic Beta Cells in Insulin-Dependent Diabetes. Diab. Metab. Rev. 1992; 8: 209–227
   PubMed Web of Science ®Google Scholar
• Hansen A. K., Dagnaes-Hansen F. An introduction to the use of rodent models in diabetes research. Moellegaard Ltd, Bomholdtgaard Ltd., LI. Skensved, Ry. 1990
   Google Scholar
• Miyazaki J.-I., Araki K., Yamato E., et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinol. 1990; 127: 126–132
   PubMed Web of Science ®Google Scholar
• Sutton R., Peters M., McShane P., Gray D. W. R., Morris P. J. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplant 1986; 42: 689–691
   PubMed Web of Science ®Google Scholar
• Josefsen K., Hansen W. A., Kjaer T. W., et al. Optimizing fluoroscens activated cell sorting (FACS) of pancreatic endocrine cells. Diabetes 1990; 39(suppl 1)149A
   Google Scholar
• Josefsen K., Stenvang J.-P., Kindmark H., et al. Flourescence-activated cell sorted rat islet cells and studies of the insulin secretory process. J. Endocrinol. 1996; 149: 145–154
   PubMedGoogle Scholar
• Charles A. M., Suzuki M., Waldeck N., et al. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J. Immunol. 1983; 130: 1189–94
   PubMed Web of Science ®Google Scholar
• Davalli A. M., Ricordi C., Socci C., et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J. Clin. Endocrin. Metab. 1991; 72: 202–208
   PubMed Web of Science ®Google Scholar
• Davalli A. M., Pontirollo A. E., Socci C., et al. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: Evidence supporting specific desensitization rather than beta-cell exhaustion. J. Clin. Endocrin. Metab. 1992; 74: 790–794
   Google Scholar
• Boitard C. Review. The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects. Diabetologia 1992; 35: 1101–1112
   Google Scholar
• Boitard C., Larger E., Timsit J., Sempe P., Bach J. F. IDDM: an islet or an immune disease?. Diabetologia 1994; 37(suppl 2)S90–S98
   Google Scholar
• Kæmpe O., Anderson A., Bjørk E., Hallberg A., Karlsson F. A. High-Glucose Stimulation of 64,00-Mr Islet Cell Autoantigen Expression. Diabetes 1989; 38: 1326–1328
   Google Scholar